Journal article icon

Journal article

Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Trial.

Abstract:

UNLABELLED: Patients with cognitive impairment (CI) often do not receive secondary fracture prevention. Use of zoledronic acid led to a similar reduction in re-fracture risk but the survival benefit was limited to those without CI. INTRODUCTION: We tested whether the effects of zoledronic acid (Zol) on re-fracture and mortality differed in patients presenting with a hip fracture by cognitive status. METHODS: We used data from the Health Outcomes and Reduced Incidence with Zoledronic Acid Once...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1007/s00198-013-2420-8

Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, NDORMS
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, NDORMS
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, NDORMS
Expand authors...
Journal:
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Volume:
25
Issue:
1
Pages:
77-83
Publication date:
2014-01-05
DOI:
EISSN:
1433-2965
ISSN:
0937-941X
URN:
uuid:dd72f058-9fc2-422b-a789-79fc0bd0e56d
Source identifiers:
411145
Local pid:
pubs:411145

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP